During men’s health month in June, benign prostatic hyperplasia is a condition many men may seek advice from their physicians on how to treat.
Nearly half of men between the ages 51 to 60 have BPH, or an enlarged prostate, and the incidence increases every decade of life. In some men, if left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones and incontinence.
Surgical treatments for BPH may require men to consider trade-offs between symptom relief and side effects, according to Dr. Roscoe Nelson, an Abrazo Arrowhead Hospital urologist.
Abrazo Arrowhead Campus, 18701 N. 67th Ave., Glendale is now offering aquablation therapy using waterjet ablation for treatment of lower urinary tract symptoms due to BPH.
Aquablation therapy is a different type of treatment for BPH, Nelson explained. It’s a minimally invasive option that uses the power of water delivered with robotic precision to provide symptom relief. The system combines real-time, multi-dimensional imaging, automated robotic technology and heat-free waterjet ablation technology for targeted, controlled and immediate removal of prostate tissue.
The therapy has been shown to have predictable and reproducible outcomes, independent of prostate anatomy and prostate size, said Nelson. In clinical studies, the therapy has shown to provide symptom relief with low rates of complications.
Editor’s Note: Keith Jones is Abrazo Health media contact.
No comments on this item Please log in to comment by clicking here